Tenet Reports Results for the First Quarter Ended March 31, 2019

Go back to Tenet Reports Results for the First Quarter Ended March 31, 2019

Tenet Healthcare (THC) Tops Q1 EPS by 25c, Revenues Beat; Offers Q2 & FY19 Revenue Mid-Point Guidance Above Consensus, Provides 2Q/FY19 EPS Views

April 29, 2019 4:18 PM EDT

Tenet Healthcare (NYSE: THC) reported Q1 EPS of $0.54, $0.25 better than the analyst estimate of $0.29. Revenue for the quarter came in at $4.55 billion versus the consensus estimate of $4.51 billion.

Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $27 million or $0.26 per diluted share in the first quarter of 2019 due in part to a $47 million pre-tax loss from the extinguishment of debt or $0.45 per diluted share.Adjusted diluted earnings per share from continuing operations were $0.54 in the first quarter of 2019, above the high end of the Companys... More